dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate

C58H70BBrK2N12O7 — CID 161258764

About dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate

dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate (PubChem CID 161258764) has the molecular formula C58H70BBrK2N12O7 and a molecular weight of 1216.19 g/mol. Its IUPAC name is dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate.

Molecular Properties

• Compound Name: dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate
• PubChem CID: 161258764
• Molecular Formula: C58H70BBrK2N12O7
• Molecular Weight: 1216.19 g/mol
• Exact Mass: 1214.40
• IUPAC Name: dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate
• SMILES: C.CCCN1Cc2c(-c3cccc4cc(-c5cnn(C)c5)ncc34)nc(C3CC3)n2CC1=O.CCCN1Cc2c(Br)nc(C3CC3)n2CC1=O.Cn1cc(-c2cc3cccc(B4OC(C)(C)C(C)(C)O4)c3cn2)cn1.O=CO[O-].[H-].[K+].[K+]
• InChI: InChI=1S/C25H26N6O.C19H22BN3O2.C12H16BrN3O.CH2O3.CH4.2K.H/c1-3-9-30-14-22-24(28-25(16-7-8-16)31(22)15-23(30)32)19-6-4-5-17-10-21(26-12-20(17)19)18-11-27-29(2)13-18;1-18(2)19(3,4)25-20(24-18)16-8-6-7-13-9-17(21-11-15(13)16)14-10-22-23(5)12-14;1-2-5-15-6-9-11(13)14-12(8-3-4-8)16(9)7-10(15)17;2-1-4-3;;;;/h4-6,10-13,16H,3,7-9,14-15H2,1-2H3;6-12H,1-5H3;8H,2-7H2,1H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1
• InChIKey: ZFXNGZARFPUMEU-UHFFFAOYSA-M
• XLogP: 2.53
• TPSA: 205.50 Ų
• H-Bond Acceptors: 17
• Rotatable Bonds: 11
• Heavy Atoms: 81
• Complexity: —

Lipinski Rule of Five

2 violations

Rule	Value
MW ≤ 500	1216.19
LogP ≤ 5	2.53
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	17

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate?

The IUPAC name of dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate (CID 161258764) is dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate.

What is the SMILES notation for dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate?

The canonical SMILES for dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate is C.CCCN1Cc2c(-c3cccc4cc(-c5cnn(C)c5)ncc34)nc(C3CC3)n2CC1=O.CCCN1Cc2c(Br)nc(C3CC3)n2CC1=O.Cn1cc(-c2cc3cccc(B4OC(C)(C)C(C)(C)O4)c3cn2)cn1.O=CO[O-].[H-].[K+].[K+].

What is the InChIKey of dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate?

The InChIKey is ZFXNGZARFPUMEU-UHFFFAOYSA-M. The full InChI is InChI=1S/C25H26N6O.C19H22BN3O2.C12H16BrN3O.CH2O3.CH4.2K.H/c1-3-9-30-14-22-24(28-25(16-7-8-16)31(22)15-23(30)32)19-6-4-5-17-10-21(26-12-20(17)19)18-11-27-29(2)13-18;1-18(2)19(3,4)25-20(24-18)16-8-6-7-13-9-17(21-11-15(13)16)14-10-22-23(5)12-14;1-2-5-15-6-9-11(13)14-12(8-3-4-8)16(9)7-10(15)17;2-1-4-3;;;;/h4-6,10-13,16H,3,7-9,14-15H2,1-2H3;6-12H,1-5H3;8H,2-7H2,1H3;1,3H;1H4;;;/q;;;;;2*+1;-1/p-1.

What are the key properties of dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate?

dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate has a molecular weight of 1216.19 g/mol, XLogP of 2.53, 11 rotatable bonds, 0 hydrogen bond donors, and 17 hydrogen bond acceptors.

Where does this data come from?

All data for dipotassium;1-bromo-3-cyclopropyl-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(1-methylpyrazol-4-yl)isoquinolin-8-yl]-7-propyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;hydride;methane;3-(1-methylpyrazol-4-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline;oxido formate is sourced from PubChem (CID 161258764), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).